Catalyst
Slingshot members are tracking this event:
Pfizer's (PFE) Prevenar Approved in China for the Prevention of Invasive Pneumococcal Disease in Infants and Children Aged Six Weeks to Fifteen Months
Do you think this event is important to the companies below? How will it affect their stock price?
| Related Companies | Importance
|
Impact on Stocks
|
||||
|---|---|---|---|---|---|---|
| PFE |
|
|
||||
Additional Information
Slingshot Insights Explained
Catalyst Date
Occurred on:
Nov 02, 2016
Related Projects
-
Don’t see a project related to the catalyst you care about?
Related Keywords
Prevenar, China, Prevention, Invasive Pneumococcal Disease, Infants, Children, Six Weeks To Fifteen Months
